Healthcare Services

Gastroparesis Market Acceleration Amidst Diabetes Trends Continues To Impact The Growth Of The Gastroparesis Market

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Gastroparesis Market Between 2026 And 2030?

The gastroparesis market size has demonstrated considerable growth over the past few years. It is set to increase from $7.15 billion in 2025 to $7.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.1%. The expansion observed in the historic period stems from influences such as diabetes-related gastric disorders, the utilization of antiemetic medications, hospital-based GI care, dietary management approaches, and the presence of diagnostic imaging.

The gastroparesis market is projected to experience robust expansion over the coming years. Its valuation is set to reach $9.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast timeframe is attributable to breakthroughs in implantable stimulation devices, the expansion of outpatient treatment approaches, an increasing diabetic populace, the push for symptom-focused therapeutic interventions, and enhanced clinical understanding. Key trends identified for the forecast period encompass a greater reliance on prokinetic drugs, the wider integration of gastric electrical stimulation devices, an elevated emphasis on managing diet and lifestyle, the proliferation of less invasive surgical choices, and more effective diagnosis of diabetic gastroparesis.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Strategic Drivers Are Supporting The Gastroparesis Market Development?

The increasing prevalence of diabetes is anticipated to stimulate growth within the gastroparesis market. Diabetes, a chronic medical condition characterized by elevated blood glucose levels due to the body’s inability to produce or effectively use insulin, significantly raises the likelihood of developing gastroparesis by expanding the at-risk population. For instance, in April 2025, the International Diabetes Federation, a Belgium-based advocacy organization, reported that nearly one in nine adults globally, equating to 589 million individuals, are currently living with diabetes. Among these, an estimated 252 million are unaware of their condition, thereby placing them at higher risk of serious complications and early death. Therefore, the rapid surge in the prevalence of diabetes is driving the gastroparesis market.

Which Segment Groups Define The Gastroparesis Market Landscape?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

What Trends Are Influencing The Gastroparesis Market?

Companies operating within the gastroparesis market are actively engaged in developing new drugs to boost their market profitability. Medications used to manage gastroparesis serve various functions to alleviate the symptoms associated with slow stomach emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company, announced that the U.S. FDA had accepted the New Drug Application for Tradipitant, which represents a hopeful advancement for its potential approval in treating gastroparesis. The FDA has set September 18, 2024, as the Prescription Drug User Fee Act (PDUFA) decision date for Tradipitant. If approved, Tradipitant would become the first novel FDA-approved drug for gastroparesis in over 40 years, signifying a major milestone as the first drug in more than three decades to undergo specific FDA review for gastroparesis.

Which Companies Are Engaged In The Gastroparesis Market Environment?

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Access The Complete Gastroparesis Market Report:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Holds The Largest Share In The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastroparesis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2026, By The Business Research Company

Gastric Cancer Diagnostic Procedure Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Germ Cell Tumor Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/germ-cell-tumor-global-market-report

Gastrointestinal Endoscopy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-endoscopy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795